879402-30-9

Basic information

• Product Name: Acetamide, 2-chloro-N-[[(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl]methyl]-
• Synonyms: (2S)-N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}chloroacetamide
• CAS NO: 879402-30-9
• Molecular Formula: C14H17Cl3N2O2
• Molecular Weight: 351.66
• Mol File: 879402-30-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Acetamide, 2-chloro-N-[[(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl]methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, 2-chloro-N-[[(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl]methyl]-(879402-30-9)
• EPA Substance Registry System: Acetamide, 2-chloro-N-[[(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl]methyl]-(879402-30-9)

Safety Data

• Hazardous Substances Data: 879402-30-9(Hazardous Substances Data)

Upstream product

• 610305-43-6 2-{[(2R)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-1H-isoindole-1,3-(2H)-dione 
• 79-04-9 chloroacetyl chloride 
• 407640-11-3 (2S)-2-aminomethyl-4-(3,4-dichlorobenzyl)morpholine 

Downstream Products

• 879399-82-3 (2S)-[4-(carboxymethyl)thiazol-2-ylthio]-N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}acetamide 
• 1002092-12-7 (2S)-[4-(carboxymethyl)thiazol-2-ylthio]-N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}acetamide hydrobromide 
• 879402-31-0 (2S)-N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}chloroacetamide hydrochloride 
• 921211-93-0 (S)-2-acetylsulfanyl-N-((4-((3,4-dichlorophenyl)methyl)morpholin-2-yl)methyl)acetamide 

Relevant articles and documents

THERAPEUTIC AGENT FOR OPHTHALMIC DISEASE

The present invention provides a therapeutic agent or prophylactic agent for an ophthalmic disease caused by ocular angiogenesis, which contains a morpholine compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) a

MORPHOLINE COMPOUND

A compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like; ring B is arylene optionally having substituent(s) and the like; m=0-2; n=1-5; X is a bond and the like; Y is a bond and the like; and Z is hydrogen atom and the like or a pharmaceutically acceptable salt thereof, and a hydrate or solvate thereof have affinity for CCR3, and can be pharmaceutical products for the treatment and/or prophylaxis of immune or inflammatory diseases.